These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3467118

  • 1. Differential expression of tumor target binding and cytolytic activities in bone marrow culture-derived macrophages.
    Lee KC, La Posta VJ.
    J Natl Cancer Inst; 1986 Dec; 77(6):1287-97. PubMed ID: 3467118
    [Abstract] [Full Text] [Related]

  • 2. Functional heterogeneity of culture-grown bone marrow-derived macrophages. II. Lymphokine stimulation of antigen-presenting function.
    Lee KC, Wong M.
    J Immunol; 1982 Jun; 128(6):2487-92. PubMed ID: 6978905
    [Abstract] [Full Text] [Related]

  • 3. Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines.
    Lee KC, Wong M, McIntyre D.
    J Immunol; 1981 Jun; 126(6):2474-9. PubMed ID: 6971902
    [Abstract] [Full Text] [Related]

  • 4. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.
    Shibata Y, Volkman A.
    J Immunol; 1985 Dec; 135(6):3897-904. PubMed ID: 2933455
    [Abstract] [Full Text] [Related]

  • 5. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
    Fernandez-Cruz E, Ulich T, Schreiber RD.
    J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO, Johnson WJ, Marino PA.
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [Abstract] [Full Text] [Related]

  • 7. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC, Lohmann-Matthes ML, Domzig W, Kiessling R, Haller O.
    Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of selective tumor cell binding by activated murine macrophages in response to phorbol myristate acetate.
    Somers SD, Adams DO.
    J Immunol; 1986 Mar 15; 136(6):2323-32. PubMed ID: 3512713
    [Abstract] [Full Text] [Related]

  • 9. Establishment and characterization of murine bone marrow-derived spontaneously immortalized cell lines and clones expressing properties of normal macrophages.
    Loewenstein J, Yamin A, Gallily R.
    Exp Hematol; 1987 Jul 15; 15(6):685-94. PubMed ID: 3595767
    [Abstract] [Full Text] [Related]

  • 10. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M, Matzku S.
    Immunobiology; 1983 May 15; 164(5):349-60. PubMed ID: 6603412
    [Abstract] [Full Text] [Related]

  • 11. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K, Kikuchi H, Oda Y, Moritake K, Yamasaki T.
    No To Shinkei; 1993 Jun 15; 45(6):525-30. PubMed ID: 8363848
    [Abstract] [Full Text] [Related]

  • 12. Activation of cytotoxic activity in cultures of bone marrow-derived macrophages by indomethacin.
    Voth R, Storch E, Hüller K, Kirchner H.
    Eur J Immunol; 1987 Jan 15; 17(1):145-8. PubMed ID: 3102252
    [Abstract] [Full Text] [Related]

  • 13. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y, Yamasaki T, Fukuda M, Moritake K.
    No To Shinkei; 1995 Apr 15; 47(4):349-55. PubMed ID: 7772402
    [Abstract] [Full Text] [Related]

  • 14. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S, Lint TF.
    J Immunol; 1987 Feb 15; 138(4):1303-9. PubMed ID: 3100634
    [Abstract] [Full Text] [Related]

  • 15. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
    Somers SD, Whisnant CC, Adams DO.
    J Immunol; 1986 Feb 15; 136(4):1490-6. PubMed ID: 3080524
    [Abstract] [Full Text] [Related]

  • 16. Regulation of a murine macrophage haemagglutinin (sheep erythrocyte receptor) by a species-restricted serum factor.
    Crocker PR, Hill M, Gordon S.
    Immunology; 1988 Dec 15; 65(4):515-22. PubMed ID: 3220506
    [Abstract] [Full Text] [Related]

  • 17. [The cytolytic function of mononuclear phagocytes. II. Factors that determine the binding and lysis of tumor cells by activated macrophages].
    Vasil'ev VIu, Krotkova MV, Popova EV, Shatrova AN.
    Tsitologiia; 1990 Dec 15; 32(3):275-81. PubMed ID: 2219450
    [Abstract] [Full Text] [Related]

  • 18. Macrophage-mediated tumor cell killing: lack of dependence on the cyclooxygenase pathway of prostaglandin synthesis.
    Shaw JO, Russell SW, Printz MP, Skidgel RA.
    J Immunol; 1979 Jul 15; 123(1):50-4. PubMed ID: 109539
    [Abstract] [Full Text] [Related]

  • 19. Tumoricidal macrophages isolated from liver granulomas of Schistosoma mansoni-infected mice.
    Loveless SE, Wellhausen SR, Boros DL, Heppner GH.
    J Immunol; 1982 Jan 15; 128(1):284-8. PubMed ID: 7054278
    [Abstract] [Full Text] [Related]

  • 20. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML, Domzig W, Taskov H.
    Eur J Immunol; 1979 Apr 15; 9(4):261-6. PubMed ID: 467489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.